Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study

Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study have?

Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study has 2 citations in the OpenAlex counts ScholarIQ stores.

When was Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study published?

Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study has 2021 year in the ScholarIQ index.

What is the open-access status of Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study?

Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study has green oa status in the ScholarIQ index.

What is the OpenAlex record for Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study?

The OpenAlex for Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study is on the source record.